Recently, a group of Lyme disease patients in the United States filed a lawsuit against several major health insurance companies and a group of Lyme disease specialists seeking treble damages for RICO Act (Racketeer Influenced and Corrupt Organizations Act) and Sherman Act antitrust violations. Four months earlier, Dr. Sin Hang Lee also initiated a legal action against the CDC for anti-competitive campaign to stifle the use and availability of his DNA-based direct test to diagnose Lyme disease. More recently, court materials surfaced which show credible reasons to believe that the role of Yale University in suppressing development and use of direct detection methods in the diagnosis of Lyme disease at the early stage of infection for patient care should also be scrutinized by the media and the lawyers of the RICO suit.

Published in Blog
Saturday, 30 September 2017 13:57

Trust or distrust?

The first part of the article about the careless way Youth Care organization ‘Safe Home’ in which conducts itself calls into question if they contribute to social cohesion and safety in this way. Why can a Confidence doctor with confirmation bias do a PhD? Why does this organization train other professionals to suspect child abuse in a long list of illnesses and to paint nearly all Dutch parents black?

Published in Blog

On September 6, 2017, a Dutch judge ruled that health insurer IZZ has to pay for longterm Lyme treatment. This is not only good news for this particular patient, but it also creates a legal precedent for others. Both within the Netherlands as possibly also in other countries.

Published in Blog
Saturday, 23 September 2017 21:37

A letter to the CDC

The European Centers for Disease Control and Prevention (ECDC) recently announced a new list of the thirty most dangerous infectious diseases, which included Lyme Borreliose (LB). According to the American CDC, LB is the fastest spreading vector-borne disease in North America. Recently a group of 15 authors even publicly admitted that the current serological tests are so unreliable that they encourage to stop testing most patients with suspected infection. Then why is the available direct DNA test for Lyme not made available to the public in order to detect LB infection as early as possible? This question was asked to the new director of the CDC.
Published in Blog

In the USA an unprecedented anti-trust law suit of $57 million is being prepared against the CDC. They are accused of deliberately suppressing the use of an accurate DNA direct diagnostics for Lyme disease. You can read about the aim and potential impact of this lawsuit in this article.

Published in Blog
Wednesday, 14 December 2016 13:23

Father takes Dutch health insurance to court

Marleen (32) werkte als psychiatrisch verpleegkundige, totdat zij enkele jaren geleden ineens steeds zieker werd. Zij vond de oorzaak van haar klachten en vond ook een arts die haar goed kon behandelen. Maar haar ziektekostenverzekeraar IZZ weigerde dit te vergoeden. Toen haar vader ontdekte hoeveel zieke mensen zoals zij in de verdrukking komen door oneigenlijke argumenten, startte hij een rechtszaak. Zijn insteek is om zowel vergoeding voor Marleen af te dwingen als jurisprudentie te creëren waar andere patiënten door geholpen zijn. 

Published in Blog